Ulla C. Lindqvist

Uppsala, C, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Rare coding variants in NOX4 link high ROS levels to psoriatic arthritis mutilans.

Rare coding variants in NOX4 link high ROS levels to psoriatic arthritis mutilans.

Journal: EMBO molecular medicine

Published: June 14, 2023

Management of Peripheral Arthritis in Patients With Psoriatic Arthritis: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations.

Management of Peripheral Arthritis in Patients With Psoriatic Arthritis: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations.

Journal: The Journal of rheumatology

Published: December 01, 2022

Management of Peripheral Arthritis in Patients With Psoriatic Arthritis: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations.

Management of Peripheral Arthritis in Patients With Psoriatic Arthritis: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations.

Journal: The Journal of rheumatology

Published: June 27, 2022

Long-term Outcomes and Prognosis in New-Onset Psoriasis.

Long-term Outcomes and Prognosis in New-Onset Psoriasis.

Journal: JAMA dermatology

Published: April 14, 2021

Comorbidities in a Cohort of 66 Patients With Psoriatic Arthritis Mutilans-Results From the Nordic PAM Study.

Comorbidities in a Cohort of 66 Patients With Psoriatic Arthritis Mutilans-Results From the Nordic PAM Study.

Journal: Frontiers in medicine

Published: November 17, 2020

Health-related quality of life in early psoriatic arthritis compared with early rheumatoid arthritis and a general population.

Health-related quality of life in early psoriatic arthritis compared with early rheumatoid arthritis and a general population.

Journal: Seminars in arthritis and rheumatism

Published: July 10, 2020

HLA-B*27 is significantly enriched in Nordic patients with psoriatic arthritis mutilans.

HLA-B*27 is significantly enriched in Nordic patients with psoriatic arthritis mutilans.

Journal: Clinical and experimental rheumatology

Published: April 20, 2020

Radiographic scoring systems for psoriatic arthritis are insufficient for psoriatic arthritis mutilans: results from the Nordic PAM Study.

Radiographic scoring systems for psoriatic arthritis are insufficient for psoriatic arthritis mutilans: results from the Nordic PAM Study.

Journal: Acta radiologica open

Published: November 03, 2019

Circulating microRNAs in extracellular vesicles as potential biomarkers for psoriatic arthritis in patients with psoriasis.

Circulating microRNAs in extracellular vesicles as potential biomarkers for psoriatic arthritis in patients with psoriasis.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: July 30, 2019

Hyaluronan concentration and molecular mass in psoriatic arthritis: biomarkers of disease severity, resistance to treatment, and outcome.

Hyaluronan concentration and molecular mass in psoriatic arthritis: biomarkers of disease severity, resistance to treatment, and outcome.

Journal: Scandinavian journal of rheumatology

Published: April 30, 2019

Psoriatic arthritis – a challenge for patients and physicians

Psoriatic arthritis – a challenge for patients and physicians

Journal: Lakartidningen

Published: January 03, 2018

Disease activity in and quality of life of patients with psoriatic arthritis mutilans: the Nordic PAM Study.

Disease activity in and quality of life of patients with psoriatic arthritis mutilans: the Nordic PAM Study.

Journal: Scandinavian journal of rheumatology

Published: March 10, 2017

Showing 1-12 of 25

Last Updated: 09/26/2026